- Home
- STRRP vs GALT Comparison
STRRP vs GALT Comparison
Compare STRRP & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRRP
- GALT
- Stock Information
- Founded
- STRRP N/A
- GALT 2000
- Country
- STRRP United States
- GALT United States
- Employees
- STRRP 171
- GALT N/A
- Industry
- STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- STRRP Health Care
- GALT Health Care
- Exchange
- STRRP Nasdaq
- GALT Nasdaq
- Market Cap
- STRRP N/A
- GALT 147.8M
- IPO Year
- STRRP N/A
- GALT N/A
- Fundamental
- Price
- STRRP $9.10
- GALT $1.04
- Analyst Decision
- STRRP
- GALT Strong Buy
- Analyst Count
- STRRP 0
- GALT 1
- Target Price
- STRRP N/A
- GALT $11.00
- AVG Volume (30 Days)
- STRRP N/A
- GALT 1.1M
- Earning Date
- STRRP N/A
- GALT 11-13-2024
- Dividend Yield
- STRRP N/A
- GALT N/A
- EPS Growth
- STRRP N/A
- GALT N/A
- EPS
- STRRP N/A
- GALT N/A
- Revenue
- STRRP N/A
- GALT N/A
- Revenue This Year
- STRRP N/A
- GALT N/A
- Revenue Next Year
- STRRP N/A
- GALT N/A
- P/E Ratio
- STRRP N/A
- GALT N/A
- Revenue Growth
- STRRP N/A
- GALT N/A
- 52 Week Low
- STRRP N/A
- GALT $0.73
- 52 Week High
- STRRP N/A
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- STRRP 46.18
- GALT 20.80
- Support Level
- STRRP $9.07
- GALT $1.80
- Resistance Level
- STRRP $9.36
- GALT $2.36
- Average True Range (ATR)
- STRRP 0.05
- GALT 0.27
- MACD
- STRRP 0.00
- GALT -0.08
- Stochastic Oscillator
- STRRP 56.67
- GALT 15.07
About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.